Anatara Lifesciences Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anatara Lifesciences Ltd with three other companies in this sector in AUSTRALIA : Cann Global Ltd (2019 sales of 603,932.00 Australian Dollars [US$424,111.25 ] ), Recce Pharmaceuticals Ltd (686,622.00 Australian Dollars [US$482,180.30 ] ), and MGC Pharmaceuticals Ltd (858,087.00 Australian Dollars [US$602,591.60 ] ).

Sales Analysis. During the year ended June of 2019, sales at Anatara Lifesciences Ltd were A$663,405.00 (US$465.88 thousand). This is an increase of 64.9% versus 2018, when the company's sales were A$402,355.00 . Despite this increase, sales are still well below the level achieved in 2017, when Anatara Lifesciences Ltd reported sales of A$3.15 million.